Clinical Trial Update: Central Nervous System(CNS) Efficacy of Dacomitinib [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing CNS efficacy of dacomitinib in non-small cell lung cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Dacomitinib (dacomitinib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non Small Cell Lung Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN